{"title":"斯特林制药收购NewChem","authors":"None Rick Mullin","doi":"10.1021/cen-10135-buscon13","DOIUrl":null,"url":null,"abstract":"Sterling Pharma Solutions, a UK-based contract development and manufacturing organization serving the drug industry, has acquired NewChem Technologies, a pharmaceutical contract research firm that spun out from Newcastle University’s School of Chemistry in 2002. The firm, located in Newcastle upon Tyne’s Biosphere innovation hub, will coordinate efforts with Sterling’s early-phase development center in Cary, North Carolina. The deal includes all of NewChem’s assets and employees.","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"8 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sterling Pharma buys NewChem\",\"authors\":\"None Rick Mullin\",\"doi\":\"10.1021/cen-10135-buscon13\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sterling Pharma Solutions, a UK-based contract development and manufacturing organization serving the drug industry, has acquired NewChem Technologies, a pharmaceutical contract research firm that spun out from Newcastle University’s School of Chemistry in 2002. The firm, located in Newcastle upon Tyne’s Biosphere innovation hub, will coordinate efforts with Sterling’s early-phase development center in Cary, North Carolina. The deal includes all of NewChem’s assets and employees.\",\"PeriodicalId\":9517,\"journal\":{\"name\":\"C&EN Global Enterprise\",\"volume\":\"8 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"C&EN Global Enterprise\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1021/cen-10135-buscon13\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"C&EN Global Enterprise","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1021/cen-10135-buscon13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Sterling Pharma Solutions, a UK-based contract development and manufacturing organization serving the drug industry, has acquired NewChem Technologies, a pharmaceutical contract research firm that spun out from Newcastle University’s School of Chemistry in 2002. The firm, located in Newcastle upon Tyne’s Biosphere innovation hub, will coordinate efforts with Sterling’s early-phase development center in Cary, North Carolina. The deal includes all of NewChem’s assets and employees.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
